| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genomic screening in children: BabyScreen+ v0.92 | NF2 |
Lilian Rudd gene: NF2 was added gene: NF2 was added to Genomic screening in children: BabyScreen+. Sources: Expert List cancer tags were added to gene: NF2. Mode of inheritance for gene: NF2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: NF2 were set to Schwannomatosis, vestibular MIM#101000 Review for gene: NF2 was set to GREEN Added comment: EviQ guideline: From infancy Annual neurological examination3 Annual speech and pure tone audiology with auditory brainstem evoked potentials3, 4 From 10-20 years Annual cranial and spinal MRI with gadolinium enhancement (gold standard)3, 4 Once tumours are present, MRI screening should be at least annual until the individual growth rate is established.3 The ongoing interval for follow-up imaging of tumours is dependent on tumour location and growth rate3, 4 Sources: Expert List |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||